15 Biggest Mid-Day Losers For Friday

Pluristem Therapeutics Inc. PSTI shares dipped 22.9 percent to $1.08. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.
Affimed NV AFMD shares fell 20.9 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.
Uranium Resources, Inc. URRE dropped 14.6 percent to $2.29 after the company reported a closing of $9.7 million public offering.
NF Energy Saving Corp NFEC shares fell 14 percent to $1.10. On Thursday, NF Energy Saving reported a business cooperation with an Indian company.
Naked Brand Group Inc NAKD declined 13.7 percent to $1.83. Naked Brand shares have dropped 22.06 percent over the past 52 weeks, while the S&P 500 index has gained 21.75 percent in the same period.
Delta Technology Holdings Limited DELT shares fell 13.3 percent to $1.50. On Thursday, Delta Technology posted a surge in sales for the fourth quarter.
Bristol-Myers Squibb Co BMY shares declined 9.5 percent to $50.21 after the company reported that it will not be pursuing accelerated regulatory approval for its lung cancer drug Opvido/Yervoy.
Gravity Co., LTD. (ADR) GRVY dropped 7.8 percent to $19.33 after rising 23.11 percent on Thursday.
Synergy Pharmaceuticals Inc SGYP declined 6.7 percent to $5.98. The U.S. Food and Drug Administration said it approved the company’s plecanatide, branded as Trulance, for the treatment of chronic idiopathic constipation.
Intercept Pharmaceuticals Inc ICPT dropped 4.1 percent to $109.95. Needham downgraded Intercept Pharmaceuticals from Buy to Hold.
Abraxas Petroleum Corp. AXAS shares slipped 4.1 percent to $2.58. Abraxas Petroleum priced its 25 million share offering at $2.40 per share.
Herbalife Ltd. HLF shares dropped 3.4 percent to $51.35. Herbalife issued disappointing earnings outlook for FY2017.
Stemline Therapeutics Inc STML declined 3.2 percent to $10.65 after the company reported a proposed public offering of common stock.
Equifax Inc. EFX slipped 2.2 percent to $117.54. Goldman Sachs downgraded Equifax from Neutral to Sell.
General Electric Company GE shares fell 2.1 percent to $30.56. General Electric reported in-line earnings for its latest quarter, but sales missed expectations.